新闻
2 小时之前
引进/卖出
2 小时之前
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
临床结果上市批准
2 小时之前
并购
2 小时之前
NeuroGenesis Bio Receives FDA Clearance to Proceed with Expanded Access Program for NG01 in Progressive Multiple Sclerosis
细胞疗法临床结果
8 小时之前
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep
临床结果
11 小时之前
融资
11 小时之前
TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG)
上市批准引进/卖出
11 小时之前
并购引进/卖出
11 小时之前
Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
临床结果
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
临床结果上市批准孤儿药